Folic acid reverses endothelial dysfunction induced by inhibition of tetrahydrobiopterin biosynthesis
Authors:
- Zoe L. ClarkeZCZoe L. Clarke
- Anil K. MadhavanAMAnil K. Madhavan
- Malcolm J. LewisMLMalcolm J. Lewis
- Derek LangDLDerek Lang
- 1 January 2006
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 530 (3) , 250-258
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pivotal Role for Endothelial Tetrahydrobiopterin in Pulmonary HypertensionCirculation, 2005
- Deletion of p66 shc Gene Protects Against Age-Related Endothelial DysfunctionCirculation, 2004
- Treatment of coronary heart disease with folic acid: is there a future?American Journal of Physiology-Heart and Circulatory Physiology, 2004
- Dysfunction of Endothelial Nitric Oxide Synthase and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping studyBiochemical Journal, 2002
- l-Ascorbic Acid Potentiates Endothelial Nitric Oxide Synthesis via a Chemical Stabilization of TetrahydrobiopterinJournal of Biological Chemistry, 2001
- Ascorbic Acid Enhances Endothelial Nitric-oxide Synthase Activity by Increasing Intracellular TetrahydrobiopterinJournal of Biological Chemistry, 2000
- Homocysteine-Induced Inhibition of Endothelium-Dependent Relaxation in Rabbit AortaArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Tetrahydrobiopterin synthesis inhibitors induce nitric oxide synthesis in rat aortaGeneral Pharmacology: The Vascular System, 1997
- A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes1995